{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:01:26Z","timestamp":1791334886249,"version":"4.3.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lipidjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jacl.2016.08.006","type":"journal-article","created":{"date-parts":[[2016,8,23]],"date-time":"2016-08-23T08:05:51Z","timestamp":1471939551000},"page":"1303-1310","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Disease control via intensified lipoprotein apheresis in three siblings with familial hypercholesterolemia"],"prefix":"10.1016","volume":"10","author":[{"given":"Christina","family":"Taylan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Schlune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Meissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolis","family":"A\u017eukaitis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Floris E.A.","family":"Udink ten Cate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz T.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jacl.2016.08.006_bib1","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s004390050243","article-title":"Estimation of the prevalence of familial hypercholesterolaemia in a rural Afrikaner community by direct screening for three Afrikaner founder low density lipoprotein receptor gene mutations","volume":"98","author":"Steyn","year":"1996","journal-title":"Hum Genet"},{"key":"10.1016\/j.jacl.2016.08.006_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2147\/CEOR.S43087","article-title":"Homozygous familial hypercholesterolemia (HoFH) in Germany: an epidemiological survey","volume":"5","author":"Walzer","year":"2013","journal-title":"Clinicoecon Outcomes Res"},{"issue":"2","key":"10.1016\/j.jacl.2016.08.006_bib3","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2012.02.019","article-title":"Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment","volume":"223","author":"Raal","year":"2012","journal-title":"Atherosclerosis"},{"issue":"13","key":"10.1016\/j.jacl.2016.08.006_bib4","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/eurheartj\/eht015","article-title":"Diagnosis and treatment of familial hypercholesterolaemia","volume":"34","author":"Hovingh","year":"2013","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jacl.2016.08.006_bib5","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2013.12.020","article-title":"Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers","volume":"233","author":"Besseling","year":"2014","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.jacl.2016.08.006_bib6","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.amjcard.2008.07.035","article-title":"Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia","volume":"102","author":"Kolansky","year":"2008","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.jacl.2016.08.006_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1744-9987.2008.00574.x","article-title":"Low-density lipoprotein apheresis in children with familial hypercholesterolemia: follow-up to 21 years","volume":"12","author":"Palcoux","year":"2008","journal-title":"Ther Apher Dial"},{"issue":"6","key":"10.1016\/j.jacl.2016.08.006_bib8","first-page":"583","article-title":"Extent and severity of atherosclerotic involvement of the aortic valve and root in familial hypercholesterolaemia","volume":"80","author":"Rallidis","year":"1998","journal-title":"Heart Br Card Soc"},{"issue":"9406","key":"10.1016\/j.jacl.2016.08.006_bib9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(04)15467-6","article-title":"Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia","volume":"363","author":"Wiegman","year":"2004","journal-title":"Lancet Lond Engl"},{"issue":"12","key":"10.1016\/j.jacl.2016.08.006_bib10","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0735-1097(02)02593-7","article-title":"Early statin therapy restores endothelial function in children with familial hypercholesterolemia","volume":"40","author":"de Jongh","year":"2002","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.jacl.2016.08.006_bib11","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.atherosclerosis.2014.09.031","article-title":"Familial Hypercholesterolemia in Greek children and their families: genotype-to-phenotype correlations and a reconsideration of LDLR mutation spectrum","volume":"237","author":"Mollaki","year":"2014","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.jacl.2016.08.006_bib12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/j.1744-9987.2006.00332.x","article-title":"LDL-apheresis reduces P-Selectin, CRP and fibrinogen \u2013 possible important implications for improving atherosclerosis","volume":"10","author":"Kobayashi","year":"2006","journal-title":"Ther Apher Dial"},{"issue":"7","key":"10.1016\/j.jacl.2016.08.006_bib13","doi-asserted-by":"crossref","first-page":"e101290","DOI":"10.1371\/journal.pone.0101290","article-title":"HELP LDL apheresis reduces plasma pentraxin 3 in familial hypercholesterolemia","volume":"9","author":"Zanetti","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jacl.2016.08.006_bib14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1161\/01.CIR.95.1.76","article-title":"Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans","volume":"95","author":"Tamai","year":"1997","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacl.2016.08.006_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.atherosclerosis.2009.06.010","article-title":"Efficacy criteria and cholesterol targets for LDL apheresis","volume":"208","author":"Thompson","year":"2010","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.jacl.2016.08.006_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.beem.2013.10.004","article-title":"Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children","volume":"28","author":"Page","year":"2014","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jacl.2016.08.006_bib17","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0021-9150(00)00371-3","article-title":"The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels","volume":"152","author":"Kroon","year":"2000","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.jacl.2016.08.006_bib18","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/00005650-200108000-00006","article-title":"PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations","volume":"39","author":"Varni","year":"2001","journal-title":"Med Care"},{"issue":"10","key":"10.1016\/j.jacl.2016.08.006_bib19","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1161\/01.CIR.93.10.1826","article-title":"LDL-Apheresis Atherosclerosis Regression Study (LAARS). Effect of aggressive versus conventional lipid lowering treatment on coronary atherosclerosis","volume":"93","author":"Kroon","year":"1996","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.jacl.2016.08.006_bib20","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1161\/HYPERTENSIONAHA.113.01297","article-title":"Carotid artery intima-media thickness and distensibility in children and adolescents: reference values and role of body dimensions","volume":"62","author":"Doyon","year":"2013","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.jacl.2016.08.006_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.atherosclerosis.2003.11.010","article-title":"International Panel on Management of Familial Hypercholesterolemia. Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia","volume":"173","author":"Civeira","year":"2004","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.jacl.2016.08.006_bib22","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1097\/MOL.0b013e3283402f53","article-title":"Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe","volume":"21","author":"Thompson","year":"2010","journal-title":"Curr Opin Lipidol"},{"issue":"2","key":"10.1016\/j.jacl.2016.08.006_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.atherosclerosis.2014.12.009","article-title":"Increased ambulatory arterial stiffness index in obese children","volume":"238","author":"Saner","year":"2015","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.jacl.2016.08.006_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/HYPERTENSIONAHA.110.152686","article-title":"Reference values of pulse wave velocity in healthy children and teenagers","volume":"56","author":"Reusz","year":"2010","journal-title":"Hypertension"},{"issue":"7","key":"10.1016\/j.jacl.2016.08.006_bib25","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1537-2995.2009.02135.x","article-title":"Aorta and coronary angiographic follow-up of children with severe hypercholesterolemia treated with low-density lipoprotein apheresis","volume":"49","author":"Stefanutti","year":"2009","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.jacl.2016.08.006_bib26","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jacc.2004.07.001","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines","volume":"44","author":"Grundy","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2016.08.006_bib27","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.atherosclerosissup.2015.02.013","article-title":"Efficacy, safety, and tolerability of long-term lipoprotein apheresis in patients with LDL- or Lp(a) hyperlipoproteinemia: Findings gathered from more than 36,000 treatments at one center in Germany","volume":"18","author":"Heigl","year":"2015","journal-title":"Atheroscler Suppl"},{"issue":"16","key":"10.1016\/j.jacl.2016.08.006_bib28","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","article-title":"Efficacy and safety of evolocumab in reducing lipids and cardiovascular events","volume":"372","author":"Sabatine","year":"2015","journal-title":"N Engl J Med"},{"issue":"10B","key":"10.1016\/j.jacl.2016.08.006_bib29","doi-asserted-by":"crossref","first-page":"30T","DOI":"10.1016\/S0002-9149(98)00720-6","article-title":"Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group","volume":"82","author":"McGill","year":"1998","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.jacl.2016.08.006_bib30","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.atherosclerosis.2008.07.002","article-title":"Associations of arterial tissue lipids with coronary heart disease risk factors in young people","volume":"203","author":"Malcom","year":"2009","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.jacl.2016.08.006_bib31","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.jpeds.2013.04.066","article-title":"Quality of life of young adults and adolescents with chronic kidney disease","volume":"163","author":"Tong","year":"2013","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.jacl.2016.08.006_bib32","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jpeds.2014.04.013","article-title":"Long-term quality of life and social outcome of childhood end-stage renal disease","volume":"165","author":"Tjaden","year":"2014","journal-title":"J Pediatr"},{"issue":"2","key":"10.1016\/j.jacl.2016.08.006_bib33","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/ndt\/18.2.310","article-title":"Quality of life in adults with end-stage renal disease since childhood is only partially impaired","volume":"18","author":"Groothoff","year":"2003","journal-title":"Nephrol Dial Transplant"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287416302793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287416302793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T02:53:40Z","timestamp":1536461620000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287416302793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1933287416302793"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2016.08.006","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease control via intensified lipoprotein apheresis in three siblings with familial hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2016.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 National Lipid Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}